Table 1: Implant locations, follow-up duration, tissue biotype, implant type, and pink esthetic score at baseline and follow-up.
| Patient |
Implant Site |
Follow-up (mo) |
Biotype |
Implant type |
GBR |
PES baseline |
PES follow up |
| 1 |
9 |
120 |
Thick |
Bone-level |
Yes |
7 |
6 |
| 2 |
7 |
125 |
Thick |
Bone-level |
Yes |
11 |
9 |
| 3 |
9 |
135 |
Thick |
Bone-level |
Yes |
9 |
8 |
| 4 |
10 |
122 |
Thick |
Bone-level |
No |
12 |
13 |
| 5 |
7 |
122 |
Thick |
Bone-level |
No |
11 |
10 |
| 6 |
8 |
132 |
Thick |
Tissue-level |
No |
13 |
13 |
| 7 |
11 |
125 |
Thick |
Bone-level |
No |
12 |
13 |
| 8 |
6 |
125 |
Thick |
Bone-level |
No |
12 |
11 |
| 9 |
10 |
141 |
Thick |
Tissue-level |
No |
13 |
12 |
| 10 |
7 |
141 |
Thick |
Tissue-level |
No |
12 |
12 |
| 11 |
10 |
141 |
Thick |
Tissue-level |
No |
13 |
13 |
| 12 |
7 |
141 |
Thick |
Tissue-level |
No |
13 |
14 |
| 13 |
10 |
144 |
Thick |
Tissue-level |
No |
11 |
10 |
| 14 |
7 |
144 |
Thick |
Tissue-level |
No |
11 |
9 |
| 15 |
8 |
154 |
Thick |
Tissue-level |
No |
13 |
12 |
| 16 |
10 |
130 |
Thick |
Bone-level |
No |
14 |
13 |
| 17 |
9 |
124 |
Thick |
Tissue-level |
No |
12 |
10 |
| 18 |
9 |
147 |
Thick |
Tissue-level |
No |
11 |
12 |
| 19 |
8 |
135 |
Thick |
Bone-level |
No |
11 |
10 |